Improvement in Subjective Symptoms and Tolerability in Response to Nintedanib Treatment in Elderly Patients with Idiopathic Pulmonary Fibrosis

The efficacy of nintedanib treatment in patients with idiopathic pulmonary fibrosis (IPF) was demonstrated in phase III trials. However, there is limited data on the significance of nintedanib in elderly patients aged ≥75 years. We have retrospectively evaluated 54 newly nintedanib-treated patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Takeda, Takayuki, Kunimatsu, Yusuke, Tani, Nozomi, Hashimoto, Izumi, Kurono, Yuri, Hirose, Kazuki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7141222/
https://www.ncbi.nlm.nih.gov/pubmed/32168781
http://dx.doi.org/10.3390/jcm9030755

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7141222/
https://www.ncbi.nlm.nih.gov/pubmed/32168781
http://dx.doi.org/10.3390/jcm9030755

Ejemplares similares